We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BDPT market cap is 35.52M. The company's latest EPS is USD -0.0020 and P/E is -50.00.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 10k | 16k | 19k | 17k | 29k |
| Operating Income | -235k | -255k | -637k | -309k | -228k |
| Net Income | -239k | -847k | -1.05M | -895k | -712k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 24k | 19k | 149k | 37k | 104k |
| Total Liabilities | 864k | 1.4M | 1.24M | 1.49M | 1.75M |
| Total Equity | -840k | -1.38M | -1.09M | -1.45M | -1.65M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -168k | -107k | -159k | -227k | -224k |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 124k | 100k | 237k | 169k | 259k |
| Market Cap | 35.52M |
| Price to Earnings Ratio | -50.00 |
| Price to Sales Ratio | 1,000 |
| Price to Cash Ratio | 500 |
| Price to Book Ratio | -21.46 |
| Dividend Yield | - |
| Shares Outstanding | 353.39M |
| Average Volume (1 week) | 26.75k |
| Average Volume (1 Month) | 34.93k |
| 52 Week Change | -62.78% |
| 52 Week High | 0.36 |
| 52 Week Low | 0.03 |
| Spread (Intraday) | 0.04 (30.77%) |
| Company Name | Bioadaptives Inc (PK) |
| Address |
430 s 7th street las vegas, nevada 89101 |
| Website | https://bioadaptives.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
